anti-human Pentraxin-3 monoclonal antibody Anti-Human 50 µg,Reliatech,101-M605

This antibody was produced from a hybridoma (mouse myeloma fused with spleen cells from a mouse) immunized with recombinant human Pentraxin-3, also called TSG-14.

Host

Mouse

Reactivity

Human

Application

WB

Platform ID

BAB687839318

Reliatech

Headquarters

Lindener Straße 15 38300 Wolfenbüttel Germany

Contact

Tel: +49 (0) 5331 - 8586987
Fax: +49 (0) 5331- 8586989

Product Specifications
Scientific Background
Synonyms

Specifications

Nameanti-human Pentraxin-3 monoclonal antibody Anti-Human 50 µg
Cat. No.101-M605
Accession NumberP26022
HostMouse
IsotypeIgG2
ReactivityHuman
ApplicationWB
Clone Number(#6B7)
Appearance/Formlyophilized
FormulationPBS
ReconstitutionCentrifuge vial prior to opening. Reconstitute the antibody with 500 µl sterile PBS and the final concentration is 200 µg/ml.
StorageLyophilized samples are stable for 2 years from date of receipt when stored at -20°C. Reconstituted antibody can be aliquoted and stored frozen at < -20°C for at least six months without detectable loss of activity.
Regulatory StatusFor research use only

Scientific Background

Pentraxin 3 (PTX3), TSG14, was initially identified as a TNFα or IL1β inducible gene. It belongs to the pentraxin family, which was named originally for the homopentameric structure formed by its members. The pentraxin family is divided into two subfamilies: the “short” and the “long” pentraxins with approximate molecular weights of 25 kDa and 50 kDa, respectively. TSG14 is a member of the long pentraxin subfamily, which also includes the Xenopus laevis XLPXN1, the guinea pig apexin/p50, the rat neuronal pentraxin I (NPI) and NPR, the human neuronal pentraxin II (NPTX2) and the human neuronal activityrelated pentraxin. Mature secreted TSG14 contains a pentaxinlike domain at its carboxyterminus that shares 23-28% amino acid (aa) sequence similarity to Creactive protein (CRP) and serum amyloid P component (SAP), which belongs to the short pentraxin subfamily. However, the Nterminal sequence of TSG 14 does not share aa sequence homology with any of the “short” pentaxins. Unlike CRP and SAP, which forms pentamers only, TSG14 forms both pentameric and higher ordered oligomers. Similarly to CRP and SAP, TSG14 binds to the complement cascade component C1q. However, TSG14 does not bind to phosphoethanolamine, phosphocholine, or high pyruvate agarose, which are known ligands for CRP and SAP. TSG14 is a marker of the acute phase response and is highly expressed in advanced atherosclerotic plaques. While CRP and SAP are primarily produced in the liver, TSG14 expression is strongly upregulated by TNFα, IL1β, and bacterial LPS in peripheral fibroblasts, endothelial cells, and macrophages. At the amino acid level, human and mouse TSG14 share 88% aa sequence homology. TSG14 concentration is elevated in the joint fluid of patients with rheumatoid arthritis (RA), indicating that TSG14 may be a potential mediator of immune response. TSG14 may also function in the regulation of the uptake and clearance of apoptotic cells by dendritic cells. In vivo study showed that TSG14 transgenic mice are more resistant to sepsis and endotoxemia compared to wild type during the inflammatory injury. Increased expression of TSG14 may enhance the immune response to protect the host from infection.

Synonyms

PTX3; TSG-14; TNFAIP5

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.